{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:32:01Z","timestamp":1785342721884,"version":"3.55.0"},"reference-count":70,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s295215","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:29:47Z","timestamp":1625704187000},"page":"2969-2978","source":"Crossref","is-referenced-by-count":15,"title":["Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Fortunato","family":"Morabito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica Antonia","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Vigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-632X","authenticated-orcid":true,"given":"Francesco","family":"Mendicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Todoerti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdi","family":"Al-Janazreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"D\u2019Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Antonio","family":"Canale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cutrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-419X","authenticated-orcid":true,"given":"Massimo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-0726","authenticated-orcid":true,"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41408-019-0200-1","volume":"9","author":"Moreau","year":"2019","journal-title":"Blood Cancer J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1517\/14656566.2014.919257","volume":"15","author":"Gentile","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.23736\/S0031-0808.20.04145-2","volume":"63","author":"Gentile","year":"2021","journal-title":"Panminerva Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1517\/13543784.2015.1065250","volume":"24","author":"Gentile","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3324\/haematol.2019.241513","volume":"106","author":"Gentile","year":"2021","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"643490","DOI":"10.3389\/fonc.2021.643490","volume":"11","author":"Botta","year":"2021","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"624405","DOI":"10.3389\/fonc.2021.624405","volume":"11","author":"Markovic","year":"2021","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1007\/s00277-020-04158-4","volume":"99","author":"Palmieri","year":"2020","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3324\/haematol.2019.226407","volume":"105","author":"Bringhen","year":"2020","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ajh.24621","volume":"92","author":"Gentile","year":"2017","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14656566.2016.1274973","volume":"18","author":"Uccello","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1080\/10428194.2016.1205741","volume":"58","author":"Pozzi","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"ref13","first-page":"1","volume":"6","author":"Gentile","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1517\/14656566.2013.837885","volume":"14","author":"Gentile","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/ejh.12609","volume":"95","author":"Gentile","year":"2015","journal-title":"Eur J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ajh.23641","volume":"89","author":"Morabito","year":"2014","journal-title":"Am J Hematol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"632937","DOI":"10.3389\/fimmu.2021.632937","volume":"12","author":"Jasi\u0144ski","year":"2021","journal-title":"Front Immunol"},{"key":"ref18","first-page":"166","volume":"19","author":"Maples","year":"2021","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/curroncol28010063","volume":"28","author":"Lassiter","year":"2021","journal-title":"Curr Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/cancers13040863","volume":"13","author":"Devarakonda","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/bmt.2016.94","volume":"51","author":"Martino","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1517\/14712598.2016.1136285","volume":"16","author":"Martino","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1517\/13543784.2013.788643","volume":"22","author":"Martino","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/21678707.2017.1387050","volume":"5","author":"Martino","year":"2017","journal-title":"Expert Opin Orph Drugs"},{"key":"ref25","first-page":"559","volume":"64","author":"Furner","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1517\/13543784.16.9.1467","volume":"16","author":"Musto","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.clml.2013.11.009","volume":"14","author":"Martino","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref28","first-page":"318","volume":"13","author":"Sporn","year":"1986","journal-title":"Semin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1714678","volume":"378","author":"Mateos","year":"2018","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1200\/JCO.2010.29.8216","volume":"28","author":"Palumbo","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0140-6736(83)90739-0","volume":"2","author":"McElwain","year":"1983","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bjh.16764","volume":"191","author":"Kazandjian","year":"2020","journal-title":"Br J Haematol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/10611860310001647140","volume":"11","author":"Gullbo","year":"2003","journal-title":"J Drug Target"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/00001813-200309000-00006","volume":"14","author":"Gullbo","year":"2003","journal-title":"Anticancer Drugs"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1023\/B:DRUG.0000036683.10945.bb","volume":"22","author":"Gullbo","year":"2004","journal-title":"Invest New Drugs"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bcp.2009.12.022","volume":"79","author":"Wickstrom","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"66641","DOI":"10.18632\/oncotarget.18420","volume":"8","author":"Wickstrom","year":"2017","journal-title":"Oncotarget"},{"key":"ref38","unstructured":"FDA approves Oncopeptides\u2019 PEPAXTO\u00ae (melphalan flufenamide) for patients with relapsed or refractory multiple myeloma. News release. Oncopeptides, AB; February 26, 2021. Accessed February 26, 2021."},{"key":"ref39","unstructured":"De Barbieri A Peptichemio: a synthesis of pharmacological, morpho- logical, biochemical and biomolecular investigations. In: Proceedings from the Symposium on Peptichemio, Milan, Italy, 1972."},{"key":"ref40","first-page":"1725","volume":"11","author":"Hansson","year":"1991","journal-title":"Anticancer Res"},{"key":"ref41","first-page":"321","volume":"11","author":"Lewensohn","year":"1991","journal-title":"Anticancer Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-007-9092-1","volume":"26","author":"Wickstr\u00f6m","year":"2008","journal-title":"Invest New Drugs"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1349-7006.2010.01826.x","volume":"102","author":"Wickstrom","year":"2011","journal-title":"Cancer Sci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","volume":"14","author":"Mina-Osorio","year":"2008","journal-title":"Trends Mol Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1158\/1078-0432.CCR-12-3752","volume":"19","author":"Chauhan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/cancers13071527","volume":"13","author":"Miettinen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41416-020-01237-1","volume":"124","author":"Kumari","year":"2021","journal-title":"Br J Cancer"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3727\/000000003771013071","volume":"14","author":"Gullbo","year":"2003","journal-title":"Oncol Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/1535-7163.MCT-08-0735","volume":"8","author":"Moore","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s10637-015-0299-2","volume":"33","author":"Berglund","year":"2015","journal-title":"Invest New Drugs"},{"key":"ref51","unstructured":"Gullbo J. Preclinical development of new alkylating oligopeptides for cancer therapy. Medical Sciences, Dept of Clinical PharmacologyUppsala: Uppsala University; 2003."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1158\/1535-7163.MCT-07-0156","volume":"6","author":"Wickstrom","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1758835920937891","DOI":"10.1177\/1758835920937891","volume":"12","author":"Byrgazov","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"ref54","first-page":"22034","volume":"9","author":"Wang","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1586\/14737140.7.7.945","volume":"7","author":"Falco","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref56","first-page":"7900","volume":"63","author":"Hazlehurst","year":"2003","journal-title":"Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4615-1173-1_15","volume":"112","author":"Jones","year":"2002","journal-title":"Cancer Treat Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1470-2045(01)00454-5","volume":"2","author":"McHugh","year":"2001","journal-title":"Lancet Oncol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood.V100.1.224","volume":"100","author":"Spanswick","year":"2002","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/bjh.14065","volume":"174","author":"Ray","year":"2016","journal-title":"Br J Haematol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/S2352-3026(20)30044-2","volume":"7","author":"Richardson","year":"2020","journal-title":"Lancet Haematol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/bjh.17302","volume":"193","author":"Bringhen","year":"2021","journal-title":"Br J Haematol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1200\/JCO.20.02259","volume":"39","author":"Richardson","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"abs 417","DOI":"10.1182\/blood-2020-135991","volume":"136","author":"Ocio","year":"2020","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2217\/fon-2020-0024","volume":"16","author":"Schjesvold","year":"2020","journal-title":"Future Oncol"},{"key":"ref66","unstructured":"NIH Clinical Trials. A PK study of melphalan during treatment with Melphalan Flufenamide (Melflufen) and Dex in RRMM pat with impaired renal function. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03639610. Accessed June 25, 2021."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Mateos MV, Ocio EM, Sonneveld P, et al. LIGHTHOUSE (OP-108): a phase 3 study of melflufen in combination with daratumumab versus daratumumab in patients with relapsed\/refractory multiple myeloma. EHA Congress; 2020; abs PB2018.","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS8051"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S1470-2045(14)70440-1","volume":"15","author":"San-Miguel","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1470-2045(19)30788-0","volume":"21","author":"Lonial","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=71456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=71456","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:30:14Z","timestamp":1625704214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/spotlight-on-melphalan-flufenamide-an-up-and-coming-therapy-for-the-tr-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":70,"URL":"https:\/\/doi.org\/10.2147\/dddt.s295215","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}